BIO.B insider transactions

Director Hinckley Greg K converted options into 407 units of Bio-Rad A Common Stock, increasing direct ownership by 50% to 1,215 units (SEC Form 4)

Director Pei Melinda Litherland converted options into 407 units of Bio-Rad A Common Stock, increasing direct ownership by 132% to 715 units (SEC Form 4)

Director Edwards Jeffrey L converted options into 407 units of Bio-Rad A Common Stock, increasing direct ownership by 132% to 715 units (SEC Form 4)

Director Pinkston Arnold A converted options into 407 units of Bio-Rad A Common Stock, increasing direct ownership by 132% to 715 units (SEC Form 4)

EVP, President, LSG Barry James sold $214,289 worth of Bio-Rad A Common Stock (700 units at $306.18), decreasing direct ownership by 58% to 510 units (SEC Form 4)

President & COO Divincenzo Jonathan P. converted options into 1,869 units of Bio-Rad A Common Stock and covered exercise/tax liability with 950 units of Bio-Rad A Common Stock (SEC Form 4)

EVP, Global Supply Chain Evran Sedat converted options into 1,044 units of Bio-Rad A Common Stock and covered exercise/tax liability with 335 units of Bio-Rad A Common Stock, increasing direct ownership by 47% to 2,233 units (SEC Form 4)

EVP, Global Supply Chain Evran Sedat converted options into 864 units of Bio-Rad A Common Stock and covered exercise/tax liability with 277 units of Bio-Rad A Common Stock, increasing direct ownership by 63% to 1,524 units (SEC Form 4)

EVP, Chief Financial Officer Lakkaraju Roop Kalyan converted options into 1,535 units of Bio-Rad A Common Stock and covered exercise/tax liability with 550 units of Bio-Rad A Common Stock, increasing direct ownership by 115% to 1,844 units (SEC Form 4)

EVP, Global Human Resources Corey Colleen covered exercise/tax liability with 209 units of Bio-Rad A Common Stock and converted options into 576 units of Bio-Rad A Common Stock, increasing direct ownership by 2% to 19,550 units (SEC Form 4)

EVP, President, LSG Barry James converted options into 1,056 units of Bio-Rad A Common Stock and covered exercise/tax liability with 378 units of Bio-Rad A Common Stock, increasing direct ownership by 128% to 1,210 units (SEC Form 4)

Director Allison Schwartz converted options into 92 units of Bio-Rad A Common Stock and covered exercise/tax liability with 33 units of Bio-Rad A Common Stock, increasing direct ownership by 4% to 1,456 units (SEC Form 4)

SEC Form 4 filed by President & COO Divincenzo Jonathan P.

EVP, President, CDG Engelhardt Eva Anette covered exercise/tax liability with 413 units of Bio-Rad A Common Stock and converted options into 1,152 units of Bio-Rad A Common Stock, increasing direct ownership by 471% to 896 units (SEC Form 4)

EVP, General Counsel & Sec Enloe Courtney C converted options into 768 units of Bio-Rad A Common Stock and covered exercise/tax liability with 275 units of Bio-Rad A Common Stock, increasing direct ownership by 363% to 629 units (SEC Form 4)

Chairman & CEO Schwartz Norman D converted options into 3,455 units of Bio-Rad A Common Stock and covered exercise/tax liability with 1,528 units of Bio-Rad A Common Stock, increasing direct ownership by 0.44% to 443,434 units (SEC Form 4)

SEC Form 4 filed by EVP, GBL Commercial Operations Mehta Rajat

Director Allison Schwartz converted options into 147 units of Bio-Rad A Common Stock and covered exercise/tax liability with 55 units of Bio-Rad A Common Stock, increasing direct ownership by 7% to 1,397 units (SEC Form 4)

EVP, President, LSG Barry James converted options into 602 units of Bio-Rad A Common Stock and covered exercise/tax liability with 217 units of Bio-Rad A Common Stock, increasing direct ownership by 263% to 532 units (SEC Form 4)

EVP, Global Human Resources Corey Colleen converted options into 1,102 units of Bio-Rad A Common Stock and covered exercise/tax liability with 398 units of Bio-Rad A Common Stock, increasing direct ownership by 4% to 19,183 units (SEC Form 4)

Chairman & CEO Schwartz Norman D converted options into 6,353 units of Bio-Rad A Common Stock and covered exercise/tax liability with 3,084 units of Bio-Rad A Common Stock, increasing direct ownership by 0.75% to 441,507 units (SEC Form 4)

New insider Mehta Rajat claimed no ownership of stock in the company (SEC Form 3)

EVP, President, CDG Engelhardt Eva Anette converted options into 245 units of Bio-Rad A Common Stock and covered exercise/tax liability with 88 units of Bio-Rad A Common Stock (SEC Form 4)

EVP, Chief Financial Officer Lakkaraju Roop Kalyan converted options into 1,077 units of Bio-Rad A Common Stock and covered exercise/tax liability with 386 units of Bio-Rad A Common Stock, increasing direct ownership by 448% to 845 units (SEC Form 4)

EVP, General Counsel & Sec Enloe Courtney C converted options into 186 units of Bio-Rad A Common Stock and covered exercise/tax liability with 67 units of Bio-Rad A Common Stock, increasing direct ownership by 1,145% to 129 units (SEC Form 4)

Director Pinkston Arnold A converted options into 308 units of Bio-Rad A Common Stock (SEC Form 4)

Director Pei Melinda Litherland converted options into 308 units of Bio-Rad A Common Stock (SEC Form 4)

Director Hinckley Gregory K converted options into 308 units of Bio-Rad A Common Stock (SEC Form 4)

Director Edwards Jeffrey L converted options into 308 units of Bio-Rad A Common Stock (SEC Form 4)

EVP, GBL Commercial Operations Crowley Michael sold $741,184 worth of Bio-Rad A Common Stock (3,000 units at $247.06) and exercised 3,000 units of Bio-Rad A Common Stock at a strike of $159.32 (SEC Form 4)

SEC Form 4 filed by Chairman & CEO Schwartz Norman D

SEC Form 4 filed by EVP, Chief Financial Officer Lakkaraju Roop Kalyan

SEC Form 4 filed by EVP, President, LSG Barry James

SEC Form 4 filed by EVP, General Counsel & Sec Enloe Courtney C

SEC Form 4 filed by EVP, President, CDG Engelhardt Eva Anette

SEC Form 4 filed by EVP, Global Human Resources Corey Colleen

SEC Form 4 filed by EVP, Global Supply Chain Evran Sedat

SEC Form 4 filed by President & COO Divincenzo Jonathan P.

SEC Form 4 filed by President & COO Divincenzo Jonathan P.

EVP, Global Supply Chain Evran Sedat converted options into 1,044 units of Bio-Rad A Common Stock and covered exercise/tax liability with 335 units of Bio-Rad A Common Stock, increasing direct ownership by 492% to 853 units (SEC Form 4)

New insider Divincenzo Jonathan P. claimed no ownership of stock in the company (SEC Form 3)

SEC Form 4 filed by EVP, President, CDG Engelhardt Eva Anette

SEC Form 4 filed by EVP, General Counsel & Sec Enloe Courtney C

SEC Form 4 filed by EVP, Chief Financial Officer Lakkaraju Roop Kalyan

SEC Form 4 filed by EVP, Global Supply Chain Evran Sedat

SEC Form 4 filed by Chairman & CEO Schwartz Norman D

EVP, Chief Operating Officer Last Andrew J. exercised 3,000 units of Bio-Rad A Common Stock at a strike of $299.24 and sold $989,815 worth of Bio-Rad A Common Stock (3,000 units at $329.94) (SEC Form 4)

SEC Form 4 filed by Director Allison Schwartz

SEC Form 4 filed by EVP, Global Human Resources Corey Colleen

SEC Form 4 filed by EVP, President, LSG Barry James

SEC Form 4 filed by EVP, GBL Commercial Operations Crowley Michael

SEC Form 4 filed by Director Hinckley Gregory K

SEC Form 4 filed by Director Pinkston Arnold A

SEC Form 4 filed by Director Pei Melinda Litherland

SEC Form 4 filed by Director Edwards Jeffrey L

EVP, GBL Commercial Operations Crowley Michael converted options into 2,667 units of Bio-Rad A Common Stock and covered exercise/tax liability with 1,069 units of Bio-Rad A Common Stock, increasing direct ownership by 24% to 8,171 units (SEC Form 4)

Chairman, President, and CEO Schwartz Norman D covered exercise/tax liability with 5,159 units of Bio-Rad A Common Stock and converted options into 10,477 units of Bio-Rad A Common Stock, increasing direct ownership by 1% to 438,238 units (SEC Form 4)

EVP, Global Human Resources Corey Colleen converted options into 1,956 units of Bio-Rad A Common Stock and covered exercise/tax liability with 700 units of Bio-Rad A Common Stock, increasing direct ownership by 7% to 18,479 units (SEC Form 4)

EVP, President, LSG Barry James converted options into 1,082 units of Bio-Rad A Common Stock, covered exercise/tax liability with 389 units of Bio-Rad A Common Stock and sold $205,898 worth of Bio-Rad A Common Stock (623 units at $330.49), increasing direct ownership by 91% to 147 units (SEC Form 4)

EVP, Chief Operating Officer Last Andrew J. converted options into 3,655 units of Bio-Rad A Common Stock and covered exercise/tax liability with 1,854 units of Bio-Rad A Common Stock, increasing direct ownership by 31% to 7,559 units (SEC Form 4)